Overview

Tumor-infiltrating lymphocytes (TILs) represent a cutting-edge approach in cancer immunotherapy, harnessing the body's natural defense mechanisms to combat malignancies. These specialized immune cells possess the remarkable ability to identify and eliminate cancer cells with precision, offering new hope in the fight against various forms of cancer. This on-demand webinar delves into the fascinating world of TILs, providing healthcare professionals and researchers with a comprehensive overview of this groundbreaking technology. The session is structured to cover three key areas:

  • Foundational knowledge
  • Clinical landscape
  • Manufacturing considerations

One of the webinar's focal points is the critical need to establish robust safety and efficacy benchmarks in TIL manufacturing. This discussion is crucial for ensuring the consistent production of high-quality TILs, which is essential for their successful clinical application and the advancement of personalized cancer treatments.

  • Register
    • Applicant - $100
    • Auditor - Free!
    • Committee Member - $100
    • Consultant - Free!
    • FACT Staff - Free!
    • Inspector - Free!
    • Inspector Trainee - Free!
    • Non-member - $100
    • Industry Representative - $200
    • Fellow - $50

    Continue

Already registered?
Log in to access.

Log In

Key:

Complete
Failed
Available
Locked
2023 On-Demand Webinar: Tumor Infiltrating Lymphocytes (TIL)
You must register to access.
Evaluation for 2023 On-Demand Webinar: Tumor Infiltrating Lymphocytes (TIL)
You must register to access.
Completion Certificate for 2023 On-Demand Webinar: Tumor Infiltrating Lymphocytes (TIL)
You must register to access.